Strengths And Weaknesses Of Isotype Controls In Flow Cytometry

Controls are critical for minimizing the effects of the variables in a scientific experiment so that the effect of the independent variable can be accurately measured.

In flow cytometry, there are a host of important controls necessary to properly interpret data generated in these experiments. Some of these controls include compensation, fluorescence minus one (FMO), stimulated and unstimulated, reference, and controls.

When it becomes time to publish, the proper use of these controls is critical in convincing the reviewer and reader that the data has been properly analyzed.

The isotype control is an experimental control where a sample is stained with an irrelevant antibody with the same isotype as the target antibody. Cells are gated and positivity is set based on the background staining of this isotype control.

The use of the isotype control to set negativity remains a topic of discussion and can confuse the novice to flow cytometry, especially when a reviewer may request why these controls were not included in a submitted paper.
Overall, the isotype control is one that is often overinterpreted and can provide little additional information in an analysis.

As Keeney and co-workers stated in their 1998 paper, “Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry — time to let go!”

Recent experiments suggest that isotypes might be irrelevant

(Author emphasis).

Clearly, the use of the isotype control is ingrained in the scientific community, and vendors are more than happy to sell you one (or more).

Delving deeper into this specific control and evaluating the strengths and weaknesses can help you to come to your own conclusion on if and when to use an isotype control in your flow cytometry experiments.

1. What is an isotype?

As a B cell matures, it undergoes V(D)J recombination, which results in the production of the B cell receptor (BCR). After selection in the bone marrow, the B cells circulate to secondary lymphoid organs, where they are constantly exposed to new antigens.

When the BCR binds an antigen, the B cell becomes activated and can secrete antibodies as well as generate a memory cell, to provide long-term protection.

Class switch recombination occurs in mature cells upon stimulation, and in the presence of signaling molecules. The variable region of the antibody is retained, while the constant region of the heavy chain is changed, based on the specific signal molecules present at the time. This process is illustrated below.

From: Wikimedia.org

Isotype control explained

Thus, the isotype is changed.

2. What is an isotype control?

An isotype control is an antibody to an irrelevant target that shares the same heavy and light chain as the target antibody.

For example, the anti-human CD3 antibody HIT3a has the isotype of Mouse IgG2a, κ. Thus, one would look for an isotype control with the same characteristics.

There are several assumptions that are made when an isotype control is used:

  1. There is no target for the isotype control antibody expressed on the cells of interest.   The problem with this assumption is that the target of the isotype control is not always known. For example, one can purchase Mouse IgG2a, κ, clone MOPC-173 as an isotype control for CD3 (clone HIT3a). However, the antigen details of the MOPC-173 clone, as described on the BioLegend website (and many other vendor’s sites) states: Antigen details Thus, the target is not known, it was only selected as an isotype control because of screening against various samples. This does not mean that the target is not expressed on your specific cells of interest, but only that it doesn’t bind in common tissues.
  2. The non-specific binding of the isotype control has similar characteristics to the target antibody. There are three factors to consider in antibody binding:
    • Specific binding — this is the binding of the antibody to the target of interest. This is what we are interested in.
    • Fc receptor mediated binding — this is a specific binding of the constant region of an antibody to the Fc receptor expressed on certain cell types. Generally, this is not something we are interested in, and is usually dealt by various blocking methods.
    • Non-specific binding — this is off-target binding of the antigen to any protein in the cell. If the antibody can’t find the target, there is a chance it will bind to another protein. This is often driven by antibody concentration, and one of the critical reasons for titration.Since we don’t necessarily know the target of the isotype control, it is impossible to know what the off-target binding will be. We are left with the fact that the isotype antibody has been ‘tested’ against a standard series of cells and cannot be sure that the NSB of the two reagents will be similar.
  3. The fluorochrome to protein (F/P) ratio is the same between the isotype control and the target antibody.   The F/P ratio represents the amount of fluorochrome that is bound to the antibody. In some cases (for large fluorochromes like PE and APC), this is typically in the 1/1 range. However, for smaller fluorochromes, this is not the case, and the labeling of each antibody must be optimized. Thus, unless you know the F/P ratio of both the target antibody and the isotype control, differences in staining and fluorescence could be due to an F/P difference.

3. Should I use isotype controls?

That is the real question.

In addition to the Keeney paper mentioned above, there are several papers that suggest to not rely on isotype controls, including Maecker and Trotter (2006) and Hulspas et al., (2009).

Most recently, an excellent article by Andersen and coworkers (2016) explored the question of how best to block nonspecific binding. Their work was performed on monocytes and macrophages, which contain large amounts of Fc-Receptors.

Blocking nonspecific binding

Figure 1 from Andersen et al., (2017)

This is Figure 1 from Andersen’s paper showing how, in the absence of blocking, the isotype control (IgG1) binds at a much higher level than the specific binding for Tie2, a protein known to be expressed at low levels on monocytes.

However, the plot gets more interesting as the authors explore how best to block this Fc mediated binding of Isotype controls, which they further demonstrate was specific to the Monocyte subset, which is shown in the third figure of this paper. Interestingly enough, the authors demonstrated that this nonspecific binding was only seen with the IgG1 and IgG2a isotype controls.

Binding of isotype controls

Figure 3 from Anderson et al. (2016).

The final piece from this paper is the report that different lots of the same isotype from the same vendor showed different binding responses. Again, calling into significant question the use of isotype controls in the setting of gates to determine positivity of a given antigen.

The conclusion from this paper nicely sums up the best practices researchers should be using — and it doesn’t include isotype controls. To quote from Andersen’s paper:

Summary of best practices for isotype controls

There is one, albeit small, use for isotype controls, also illustrated in the Andersen paper. An isotype control can be used to show that there was poor or incomplete blocking of specific subsets being labeled. That is it.

Looking at all the data and discussions, from the 1998 Keeney paper to the most recent work by Andersen, it is clear that the hypothesis that an isotype control can show the background or nonspecific binding on cells must be rejected. If a reviewer rejects your paper because of the lack of isotype controls, you now have the needed information to rebut those arguments. Likewise, if someone is using an isotype control to set background staining levels, this information can help them realize that they are wasting time and money by using this control for that purpose.

To learn more about the strengths and weaknesses of isotype controls in flow cytometry, and to get access to all of our advanced materials including 20 training videos, presentations, workbooks, and private group membership, get on the Flow Cytometry Mastery Class wait list.

Join Expert Cytometry's Mastery Class
Tim Bushnell, PhD
Tim Bushnell, PhD

Tim Bushnell holds a PhD in Biology from the Rensselaer Polytechnic Institute. He is a co-founder of—and didactic mind behind—ExCyte, the world’s leading flow cytometry training company, which organization boasts a veritable library of in-the-lab resources on sequencing, microscopy, and related topics in the life sciences.

Similar Articles

How To Extract Cells From Tissues Using Laser Capture Microscopy

How To Extract Cells From Tissues Using Laser Capture Microscopy

By: Tim Bushnell, PhD

Extracting specific cells still remains an important aspect of several emerging genomic techniques. Prior knowledge about the input cells helps to put the downstream results in context. The most common isolation technique is cell sorting, but it requires a single cell suspension and eliminates any spatial information about the microenvironment. Spatial transcriptomics is an emerging technique that can address some of these issues, but that is a topic for another blog.  So what does a researcher who needs to isolate a specific type of cell do? The answer lies in the technique of laser capture microdissection (LCM). Developed at the National…

The Importance Of Quality Control And Quality Assurance In Flow Cytometry (Part 4 Of 6)

The Importance Of Quality Control And Quality Assurance In Flow Cytometry (Part 4 Of 6)

By: Tim Bushnell, PhD

Incorporating quality control as a part of the optimization process in  your flow cytometry protocol is important. Take a step back and consider how to build quality control tracking into the experimental protocol.  When researchers hear about quality control, they immediately shift their attention to those operating and maintaining the instrument, as if the whole weight of QC should fall on their shoulders.   It is true that core facilities work hard to provide high-quality instruments and monitor performance over time so that the researchers can enjoy uniformity in their experiments. That, however, is just one level of QC.  As the experimental…

Understanding Clinical Trials And Drug Development As A Research Scientist

Understanding Clinical Trials And Drug Development As A Research Scientist

By: Deepak Kumar, PhD

Clinical trials are studies designed to test the novel methods of diagnosing and treating health conditions – by observing the outcomes of human subjects under experimental conditions.  These are interventional studies that are performed under stringent clinical laboratory settings. Contrariwise, non-interventional studies are performed outside the clinical trial settings that provide researchers an opportunity to monitor the effect of drugs in real-life situations. Non-interventional trials are also termed observational studies as they include post-marketing surveillance studies (PMS) and post-authorization safety studies (PASS). Clinical trials are preferred for testing newly developed drugs since interventional studies are conducted in a highly monitored…

How To Optimize Instrument Voltage For Flow Cytometry Experiments  (Part 3 Of 6)

How To Optimize Instrument Voltage For Flow Cytometry Experiments (Part 3 Of 6)

By: Tim Bushnell, PhD

As we continue to explore the steps involved in optimizing a flow cytometry experiment, we turn our attention to the detectors and optimizing sensitivity: instrument voltage optimization.  This is important as we want to ensure that we can make as sensitive a measurement as possible.  This requires us to know the optimal sensitivity of our instrument, and how our stained cells are resolved based on that voltage.  Let’s start by asking the question what makes a good voltage?  Joe Trotter, from the BD Biosciences Advanced Technology Group, once suggested the following:  Electronic noise effects resolution sensitivity   A good minimal PMT…

How To Profile DNA And RNA Expression Using Next Generation Sequencing (Part-2)

How To Profile DNA And RNA Expression Using Next Generation Sequencing (Part-2)

By: Deepak Kumar, PhD

In the first blog of this series, we explored the power of sequencing the genome at various levels. We also dealt with how the characterization of the RNA expression levels helps us to understand the changes at the genome level. These changes impact the downstream expression of the target genes. In this blog, we will explore how NGS sequencing can help us comprehend DNA modification that affect the expression pattern of the given genes (epigenetic profiling) as well as characterizing the DNA-protein interactions that allow for the identification of genes that may be regulated by a given protein.  DNA Methylation Profiling…

How To Profile DNA And RNA Expression Using Next Generation Sequencing

How To Profile DNA And RNA Expression Using Next Generation Sequencing

By: Deepak Kumar, PhD

Why is Next Generation Sequencing so powerful to explore and answer both clinical and research questions. With the ability to sequence whole genomes, identifying novel changes between individuals, to exploring what RNA sequences are being expressed, or to examine DNA modifications and protein-DNA interactions occurring that can help researchers better understand the complex regulation of transcription. This, in turn, allows them to characterize changes during different disease states, which can suggest a way to treat said disease.  Over the next two blogs, I will highlight these different methods along with illustrating how these can help clinical diagnostics as well as…

Optimizing Flow Cytometry Experiments - Part 2         How To Block Samples (Sample Blocking)

Optimizing Flow Cytometry Experiments - Part 2 How To Block Samples (Sample Blocking)

By: Tim Bushnell, PhD

In my previous blog on  experimental optimization, we discussed the idea of identifying the best antibody concentration for staining the cells. We did this through a process called titration, which  focuses on finding the best signal-to-noise ratio at the lowest antibody concentration. In this blog we will deal with sample blocking As a reminder, there are two other major binding concerns with antibodies. The first is the specific binding of the Fc fragment of the antibody to the Fc Receptor expressed on some cells. This protein is critical for the process of destroying microbes or other cells that have been…

What Is Next Generation Sequencing (NGS) And How Is It Used In Drug Development

What Is Next Generation Sequencing (NGS) And How Is It Used In Drug Development

By: Deepak Kumar, PhD

NGS methodologies have been used to produce high-throughput sequence data. These data with appropriate computational analyses facilitate variant identification and prove to be extremely valuable in pharmaceutical industries and clinical practice for developing drug molecules inhibiting disease progression. Thus, by providing a comprehensive profile of an individual’s variome — particularly that of clinical relevance consisting of pathogenic variants — NGS helps in determining new disease genes. The information thus obtained on genetic variations and the target disease genes can be used by the Pharma companies to develop drugs impeding these variants and their disease-causing effect. However simple this may allude…

How To Determine The Optimal Antibody Concentration For Your Flow Cytometry Experiment (Part 1 of 6)

How To Determine The Optimal Antibody Concentration For Your Flow Cytometry Experiment (Part 1 of 6)

By: Tim Bushnell, PhD

Over the next series of blog posts, we will explore the different aspects of optimizing a polychromatic flow cytometry panel. These steps range from figuring out the best voltage to use, which controls are critical for data interpretation, what quality control tools can be integrated into the assay; how to block cells, and more. This blog will focus on determining the optimal antibody concentration.  As a reminder about the antibody structure, a schematic of an antibody is shown below.  Figure 1: Schematic of an antibody. Figure from Wikipedia. The antibody is composed of two heavy chains and two light chains that…

Top Technical Training eBooks

Get the Advanced Microscopy eBook

Get the Advanced Microscopy eBook

Heather Brown-Harding, PhD

Learn the best practices and advanced techniques across the diverse fields of microscopy, including instrumentation, experimental setup, image analysis, figure preparation, and more.

Get The Free Modern Flow Cytometry eBook

Get The Free Modern Flow Cytometry eBook

Tim Bushnell, PhD

Learn the best practices of flow cytometry experimentation, data analysis, figure preparation, antibody panel design, instrumentation and more.

Get The Free 4-10 Compensation eBook

Get The Free 4-10 Compensation eBook

Tim Bushnell, PhD

Advanced 4-10 Color Compensation, Learn strategies for designing advanced antibody compensation panels and how to use your compensation matrix to analyze your experimental data.